
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607

Intrinsic Value
The intrinsic value of one
Shanghai Pharmaceuticals Holding Co Ltd
stock under the Base Case scenario is
51.79
CNY.
Compared to the current market price of 18.64 CNY,
Shanghai Pharmaceuticals Holding Co Ltd
is
Undervalued by 64%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Shanghai Pharmaceuticals Holding Co Ltd
Fundamental Analysis



Revenue & Expenses Breakdown
Shanghai Pharmaceuticals Holding Co Ltd
Balance Sheet Decomposition
Shanghai Pharmaceuticals Holding Co Ltd
Current Assets | 171.8B |
Cash & Short-Term Investments | 42.3B |
Receivables | 86.5B |
Other Current Assets | 43B |
Non-Current Assets | 49.4B |
Long-Term Investments | 10.2B |
PP&E | 19.3B |
Intangibles | 17B |
Other Non-Current Assets | 2.9B |
Free Cash Flow Analysis
Shanghai Pharmaceuticals Holding Co Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Shanghai Pharmaceuticals Holding Co Ltd
Revenue
|
275.3B
CNY
|
Cost of Revenue
|
-244.8B
CNY
|
Gross Profit
|
30.5B
CNY
|
Operating Expenses
|
-21.3B
CNY
|
Operating Income
|
9.2B
CNY
|
Other Expenses
|
-4.7B
CNY
|
Net Income
|
4.6B
CNY
|
Profitability Score
Profitability Due Diligence
Shanghai Pharmaceuticals Holding Co Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Score
Shanghai Pharmaceuticals Holding Co Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Shanghai Pharmaceuticals Holding Co Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Score
Shanghai Pharmaceuticals Holding Co Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Shanghai Pharmaceuticals Holding Co Ltd
According to Wall Street analysts, the average 1-year price target for
Shanghai Pharmaceuticals Holding Co Ltd
is 21.3 CNY
with a low forecast of 12.22 CNY and a high forecast of 26.15 CNY.
Dividends
Current shareholder yield for Shanghai Pharmaceuticals Holding Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Shanghai Pharmaceuticals Holding Co Ltd
stock under the Base Case scenario is
51.79
CNY.
Compared to the current market price of 18.64 CNY,
Shanghai Pharmaceuticals Holding Co Ltd
is
Undervalued by 64%.